About: Predicting Outcomes After Blunt Chest Trauma—Utility of Thoracic Trauma Severity Score, Cytokines (IL-1β, IL-6, IL-8, IL-10, and TNF-α), and Biomarkers (vWF and CC-16)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Predicting Outcomes After Blunt Chest Trauma—Utility of Thoracic Trauma Severity Score, Cytokines (IL-1β, IL-6, IL-8, IL-10, and TNF-α), and Biomarkers (vWF and CC-16) Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Predicting Outcomes After Blunt Chest Trauma—Utility of Thoracic Trauma Severity Score, Cytokines (IL-1β, IL-6, IL-8, IL-10, and TNF-α), and Biomarkers (vWF and CC-16)
Creator	Gupta, Amit Kapil, Dev Kumar, Subodh Mathur, Purva Soni, Bagaria, Vivek Bhattacharjee, Hemanga Kumari, Minu Madan, Karan Sagar, Sushma Kapil, & Soni, Dev
Source	PMC
abstract	Thoracic trauma severity score (TTSS) has been used to assess severity and risk of pulmonary complications in patients with chest trauma. The role of cytokines and biomarkers in patients with chest trauma and its association with TTSS is not well elucidated. The aim of the study was to assess the cytokines (IL-1β, IL-6, IL-8, IL-10, and TNF-α) and biomarkers (vWF, CC-16) in patients of thoracic trauma and correlate it with TTSS and patient’s outcome. This was a prospective observational study. Serum and bronchoalveolar lavage fluid samples were collected from chest trauma patients. TTSS was calculated in all patients. Suitable controls for serum and bronchoalveolar lavage (BAL) sample were selected. The outcome parameters included patient discharge or death, duration of hospital, and intensive care unit (ICU) stay. Forty-three patients were included. There was no significant correlation between the measured cytokines and biomarkers and TTSS. The mean TTSS of patients who had a fatal outcome was significantly higher than the patients who recovered. Patients with a high TTSS score had a significant prolonged ICU stay. Patients with a prolonged hospital stay had lower values of CC-16. TTSS is a useful tool to predict severity of chest trauma and prolonged ICU stay. Lower levels of CC-16 in BAL fluid of chest trauma patients were associated with prolonged hospital stay suggestive of its protective role in the airway. Longer prospective studies are required to determine the role of cytokines and biomarkers in patients with thoracic trauma in predicting the patient’s outcome.
has issue date	2020-06-07(xsd:dateTime)
bibo:doi	10.1007/s12262-020-02407-4
has license	no-cc
sha1sum (hex)	7423f06fad1af41fdb955562145bff41aa0d872f
schema:url	https://doi.org/10.1007/s12262-020-02407-4
resource representing a document's title	Predicting Outcomes After Blunt Chest Trauma—Utility of Thoracic Trauma Severity Score, Cytokines (IL-1β, IL-6, IL-8, IL-10, and TNF-α), and Biomarkers (vWF and CC-16)
has PubMed Central identifier	PMC7275928
schema:publication	Indian J Surg
resource representing a document's body	covid:7423f06fad1af41fdb955562145bff41aa0d872f#body_text
is schema:about of	named entity 'stay' named entity 'hospital' named entity 'biomarkers' named entity 'hospital' named entity 'There' named entity 'The' named entity 'values' named entity 'Blunt' named entity 'PREDICT' named entity 'BRONCHOALVEOLAR LAVAGE' named entity 'REQUIRED' named entity 'MEASURED' named entity 'DETERMINE' named entity 'BRONCHOALVEOLAR LAVAGE FLUID' named entity 'SAMPLE' named entity '27S' named entity 'HIGH' named entity 'OUTCOME' named entity 'CONTROLS' named entity '10%' named entity 'THORACIC TRAUMA' named entity 'SCORE' named entity 'chest trauma' named entity 'IL-1β' named entity 'selected' named entity 'stay' named entity 'thoracic' named entity 'suggestive' named entity 'risk' named entity 'patients' named entity 'trauma' named entity 'bronchoalveolar lavage fluid' named entity 'stay' named entity 'IL-10' named entity 'ICU' named entity 'serum' named entity 'biomarkers' named entity 'pulmonary complications' named entity 'biomarkers' named entity 'chest trauma' named entity 'IL-10' named entity 'Serum' named entity 'ICU' named entity 'IL-6' named entity 'airway' named entity 'vWF' named entity 'IL-6' named entity 'Chest Trauma' named entity 'cytokines' named entity 'serum' named entity 'lung injury' named entity 'COPD' named entity 'biomarkers' named entity 'TNF-α' named entity 'prognosis' named entity '0.45' named entity 'IL-8' named entity 'acute respiratory distress syndrome' named entity 'vWF' named entity 'China' named entity 'enzyme-linked immunosorbent assay' named entity 'chest trauma' named entity 'biomarkers' named entity 'trauma patients' named entity 'IL-10' named entity 'cytokines' named entity 'IL-8' named entity 'Acute inflammation' named entity 'TNF-α' named entity 'cytokines' named entity 'cytokines' named entity 'TNF-α'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software